Metformin is most commonly prescribed for the treatment of Type II diabetes, a disease in which the effects of insulin are desensitized leading to hyperglycemia. While the clinical effects of this generic drug are clearly established, the exact targets of metformin action remain unclear. The present study assesses the hypothesis that metformin lowers blood glucose through inhibition of pyruvate carboxylase, an anapleurotic enzyme involved in gluconeogenesis. Due to the relative low cost of metformin, it is widely accessible to communities around the world. Currently at 150 million per year, the number of users dependent on metformin for quality of life continues to rapidly increase. Thorough investigation of the drug and all possible target...
Metformin is the world’s most prescribed drug and is recommended first-line therapy for the treatmen...
Metformin is the first-choice drug for treatment of type 2 diabetes notably those associated with ob...
In addition to the antihyperglycemic effects, metformin has shown to inhibit glycation of proteins, ...
Metformin is most commonly prescribed for the treatment of Type II diabetes, a disease in which the ...
Metformin is the most commonly prescribed treatment for type II diabetes. While the clinical effects...
Metformin is the most commonly prescribed treatment for type II diabetes. While the clinical effects...
Metformin (1,1-dimethylbiguanide) is an anti-hyperglycemic agent that is commonly used in the oral t...
Rationale: The diabetes mellitus drug metformin is under investigation in cardiovascular disease, b...
For several decades, metformin has been the mainstay of treatment of type 2 diabetes (T2D), not only...
For several decades, metformin has been the mainstay of treatment of type 2 diabetes (T2D), not only...
Aims: To investigate whether metformin therapy alters circulating aromatic and branched-chain am...
Metformin has been proven to be one of the most safe and effective antihyperglycemic agent. Jean Ste...
Objective To study the effect of metformin on lactate metabolism in hepatocytes in vitro under high ...
7 pagesInternational audienceAlthough considerable efforts have been made since the 1950s to better ...
Aims To investigate whether metformin therapy alters amino acid concentrations, increased levels of ...
Metformin is the world’s most prescribed drug and is recommended first-line therapy for the treatmen...
Metformin is the first-choice drug for treatment of type 2 diabetes notably those associated with ob...
In addition to the antihyperglycemic effects, metformin has shown to inhibit glycation of proteins, ...
Metformin is most commonly prescribed for the treatment of Type II diabetes, a disease in which the ...
Metformin is the most commonly prescribed treatment for type II diabetes. While the clinical effects...
Metformin is the most commonly prescribed treatment for type II diabetes. While the clinical effects...
Metformin (1,1-dimethylbiguanide) is an anti-hyperglycemic agent that is commonly used in the oral t...
Rationale: The diabetes mellitus drug metformin is under investigation in cardiovascular disease, b...
For several decades, metformin has been the mainstay of treatment of type 2 diabetes (T2D), not only...
For several decades, metformin has been the mainstay of treatment of type 2 diabetes (T2D), not only...
Aims: To investigate whether metformin therapy alters circulating aromatic and branched-chain am...
Metformin has been proven to be one of the most safe and effective antihyperglycemic agent. Jean Ste...
Objective To study the effect of metformin on lactate metabolism in hepatocytes in vitro under high ...
7 pagesInternational audienceAlthough considerable efforts have been made since the 1950s to better ...
Aims To investigate whether metformin therapy alters amino acid concentrations, increased levels of ...
Metformin is the world’s most prescribed drug and is recommended first-line therapy for the treatmen...
Metformin is the first-choice drug for treatment of type 2 diabetes notably those associated with ob...
In addition to the antihyperglycemic effects, metformin has shown to inhibit glycation of proteins, ...